07 Jan 2001

Posorutin® (Posorutin® Augentropfen) - Deutschland

Updated: 07 Jan 2001

Posorutin®

Als Adjuvans bei Retinopathia diabetica, Retina- u. Glaskörperblutungen, subkonjunktivale Blutungen u. Thrombosen.

Posorutin® Description, Presentation and Dosage

Posorutin® Description

Posorutin® Drug Class Description

Einzelstoffe

Posorutin® Drug Description

1 ml enth.: Troxerutin 50 mg.

Posorutin® Generic Name

Posorutin® Augentropfen

Posorutin® Presentation

Posorutin® Presentation

Posorutin®

Posorutin® Manufacturer

Ursapharm

Related Learning Zones

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

Posorutin® Dosage

Posorutin® Adult Dosage

Chlorhexidindigluconat 0,05 mg (Konservierungsmittel), Natriumchlorid, Dinatriumedetat, Wasser f. Inj.-zwecke.

Posorutin® Precautions, Reactions and Contraindications

Posorutin® Special Precautions

Related Drugs - Eye Health and Disorders

Back to top